Walgreens’s recent dividend suspension and CVS's dividend freeze reflect financial headwinds and operational challenges. Read ...

UBS analyst Kevin Caliendo adjusted the price target for CVS Health (NYSE:CVS) shares, bringing it down to $59.00 from the ...

When deciding whether to buy, sell, or hold a stock, investors often rely on analyst recommendations. Media reports about ...

Walgreens Boots Alliance, a leading pharmacy chain, announced that it was suspending its dividend program, which had been ...

The CVS at 1000 South Charles Street in Federal Hill will close its doors permanently on April 2, the company said in a ...

A CVS located at 23865 FM 1314, Porter recently underwent renovations on its pharmacy. (Courtesy CVS Health Newsroom) ...

To combat thieves, drugstores across the city have put many of their goods behind lock and key, forcing shoppers to wait for ...

Failed to fetch dynamically imported module: https://finance.yahoo.com/assets/_app/immutable/nodes/105.JzBkOQ-g.js ...

CVS Health is rolling out a new customer app that aims to make it simpler and more convenient for users to manage health ...

Align Capital Partners’ (“ACP”) pet health products platform Custom Veterinary Services (“CVS” or the “Company”) recently ...

周一，UBS分析师Kevin Caliendo将CVS Health (NYSE: CVS )的目标股价从此前的62.00美元下调至59.00美元。尽管下调目标价，Caliendo仍维持对该公司股票的"中性"评级。根据InvestingPro数据，分析师对CVS的目标价区间为48.01美元至93.00美元，目前该股的市盈率为13.6倍。在评估中，Caliendo对公司第四季度每股收益 ...